The effect of intranasal corticosteroids on nasal airway obstruction, behavioral and neurocognitive dysfunction in children with adenoidal hypertrophy
Phase 2
- Conditions
- Adenoid hypertrophy with snoring and nasal congestion.Hypertrophy of adenoids
- Registration Number
- IRCT2013051813366N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 77
Inclusion Criteria
all of the infant 1-12 years with symptomatic adenoid hypertrophy without emergency indication surgery.
Exclusion criteria: hypertrophy of adenoid with tonsil hypertrophy and indication emergency surgery.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Snoring. Timepoint: 1 , 3 month after treatment. Method of measurement: history and physical examination.;Change of facial bone. Timepoint: 1 , 3 month after treatment. Method of measurement: history and physical examination.;Mouth breath. Timepoint: 1 , 3 month after treatment. Method of measurement: history and physical examination.;Rhinorea. Timepoint: 1 , 3 month after treatment. Method of measurement: history and physical examination.
- Secondary Outcome Measures
Name Time Method ocal and systemic compliction of bethamethason. Timepoint: One month after of intervention – 3 month after intervention. Method of measurement: Questionnaire sheet with clinical symptome.